Wolverine Trading
XENE icon

Wolverine Trading’s Xenon Pharmaceuticals XENE Stock Holding History

Wolverine Trading’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$898K Buy
+23,000
New +$810K ﹤0.01% 3008
2024
Q1 		– Sell
-4,900
Closed -$226K – 5413
2023
Q4 		$226K Sell
4,900
-20,400
-81% -$721K ﹤0.01% 3743
2023
Q3 		$864K Buy
+25,300
New +$946K ﹤0.01% 2233
2022
Q3 		– Sell
-6,700
Closed -$207K – 5479
2022
Q2 		$207K Sell
6,700
-7,600
-53% -$230K ﹤0.01% 3517
2022
Q1 		$431K Buy
14,300
+2,800
+24% +$83.8K ﹤0.01% 3434
2021
Q4 		$368K Buy
+11,500
New +$344K ﹤0.01% 3868

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return